Skip to main content
eScholarship
Open Access Publications from the University of California

Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome

  • Author(s): Shayya, RF
  • Rosencrantz, MA
  • Chuan, SS
  • Cook-Andersen, H
  • Roudebush, WE
  • Irene Su, H
  • Shimasaki, S
  • Chang, RJ
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889658/pdf/nihms537510.pdf
No data is associated with this publication.
Abstract

Objective To determine whether granulosa cells contribute to excess androgen production, by assessing inhibin B (Inh B) responses to hCG in women with polycystic ovary syndrome (PCOS) and in normal women. Design Prospective study. Setting Academic medical center. Patient(s) Twenty women with PCOS and 16 normal women. Intervention(s) Blood samples obtained before and 24 hours after injection of 25 μg recombinant hCG (r-hCG). Main Outcome Measure(s) Basal and stimulated Inh B, E2, androstenedione (A), and T responses after r-hCG administration. Result(s) In normal and PCOS women, r-hCG induced a significant reduction of Inh B levels. Lowered Inh B responses were not related to body mass index, PCOS status, or age by multivariate regression. Recombinant hCG significantly increased serum A and E2in both normal and PCOS women. Conclusion(s) In normal and PCOS women, Inh B production was decreased following r-hCG administration. These findings strongly suggest that in PCOS women androgen excess is not enhanced by LH-stimulated Inh B production. Clinical Trial Registration Number NCT00747617. © 2014 by American Society for Reproductive Medicine.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item